Loading…

Anti-Trichomonas vaginalis activity of ursolic acid derivative: a promising alternative

Trichomonas vaginalis is an extracellular parasite that binds to the epithelium of the human urogenital tract and causes the sexually transmitted infection, trichomoniasis. In view of increased resistance to drugs belonging to the 5-nitroimidazole class, new treatment alternatives are urgently neede...

Full description

Saved in:
Bibliographic Details
Published in:Parasitology research (1987) 2018-05, Vol.117 (5), p.1573-1580
Main Authors: Bitencourt, Fernanda Gobbi, de Brum Vieira, Patrícia, Meirelles, Lucia Collares, Rigo, Graziela Vargas, da Silva, Elenilson Figueiredo, Gnoatto, Simone Cristina Baggio, Tasca, Tiana
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c439t-d6fb169625eece368d69bc17b70b69fc2bfe60952e9fb52da5132b2ee1be59ed3
cites cdi_FETCH-LOGICAL-c439t-d6fb169625eece368d69bc17b70b69fc2bfe60952e9fb52da5132b2ee1be59ed3
container_end_page 1580
container_issue 5
container_start_page 1573
container_title Parasitology research (1987)
container_volume 117
creator Bitencourt, Fernanda Gobbi
de Brum Vieira, Patrícia
Meirelles, Lucia Collares
Rigo, Graziela Vargas
da Silva, Elenilson Figueiredo
Gnoatto, Simone Cristina Baggio
Tasca, Tiana
description Trichomonas vaginalis is an extracellular parasite that binds to the epithelium of the human urogenital tract and causes the sexually transmitted infection, trichomoniasis. In view of increased resistance to drugs belonging to the 5-nitroimidazole class, new treatment alternatives are urgently needed. In this study, eight semisynthetized triterpene derivatives were evaluated for in vitro anti- T. vaginalis activity. Ursolic acid and its derivative, 3-oxime-urs-12-en-28-oic-ursolic acid ( 9 ), presented the best anti- T. vaginalis activity when compared to other derivatives, with minimum inhibitory concentration (MIC) at 25 μM. Moreover, 9 was active against several T. vaginalis fresh clinical isolates. Hemolysis assay demonstrated that 9 presented a low hemolytic effect. Importantly, 25 μM 9 was not cytotoxic against the Vero cell lineage. Finally, we demonstrated that compound 9 acts synergistically with metronidazole against a T. vaginalis metronidazole-resistant isolate. This report reveals the high potential of the triterpenoid derivative 9 as trichomonicidal agent.
doi_str_mv 10.1007/s00436-018-5839-1
format article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_journals_2030254936</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A536151098</galeid><sourcerecordid>A536151098</sourcerecordid><originalsourceid>FETCH-LOGICAL-c439t-d6fb169625eece368d69bc17b70b69fc2bfe60952e9fb52da5132b2ee1be59ed3</originalsourceid><addsrcrecordid>eNp1kV9LHDEUxYNU3K36AfpSBvo8NjeZZDZ9W8RWQfBF8TEkmZttlpmJTWYX_PaNjn8oWPKQcM_vXE44hHwBegaUtt8zpQ2XNYVVLVZc1XBAltBwVoMS4hNZUlXeFIAvyOect5RCK5vmiCyYEi0Tsl2S-_U4hfo2Bfc7DnE0udqbTRhNH3Jl3BT2YXqsoq92Kcc-uDILXdVhCntTRPxRmeohxSHkMG4q00-YxmfhhBx602c8fbmPyd3Pi9vzy_r65tfV-fq6dg1XU91Jb0EqyQSiQy5XnVTWQWtbaqXyjlmPkirBUHkrWGcEcGYZIlgUCjt-TL7Ne0uKPzvMk97GXcnQZ80op0w0ist3amN61GH0cUrGldROrwWXIICqVaHOPqDK6XAILo7oQ5n_Y4DZ4FLMOaHXDykMJj1qoPqpIT03pEtD-qkhDcXz9SXwzg7YvTleKykAm4FcpHGD6f1H_9_6F6Lfm2E</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2030254936</pqid></control><display><type>article</type><title>Anti-Trichomonas vaginalis activity of ursolic acid derivative: a promising alternative</title><source>Springer Link</source><creator>Bitencourt, Fernanda Gobbi ; de Brum Vieira, Patrícia ; Meirelles, Lucia Collares ; Rigo, Graziela Vargas ; da Silva, Elenilson Figueiredo ; Gnoatto, Simone Cristina Baggio ; Tasca, Tiana</creator><creatorcontrib>Bitencourt, Fernanda Gobbi ; de Brum Vieira, Patrícia ; Meirelles, Lucia Collares ; Rigo, Graziela Vargas ; da Silva, Elenilson Figueiredo ; Gnoatto, Simone Cristina Baggio ; Tasca, Tiana</creatorcontrib><description>Trichomonas vaginalis is an extracellular parasite that binds to the epithelium of the human urogenital tract and causes the sexually transmitted infection, trichomoniasis. In view of increased resistance to drugs belonging to the 5-nitroimidazole class, new treatment alternatives are urgently needed. In this study, eight semisynthetized triterpene derivatives were evaluated for in vitro anti- T. vaginalis activity. Ursolic acid and its derivative, 3-oxime-urs-12-en-28-oic-ursolic acid ( 9 ), presented the best anti- T. vaginalis activity when compared to other derivatives, with minimum inhibitory concentration (MIC) at 25 μM. Moreover, 9 was active against several T. vaginalis fresh clinical isolates. Hemolysis assay demonstrated that 9 presented a low hemolytic effect. Importantly, 25 μM 9 was not cytotoxic against the Vero cell lineage. Finally, we demonstrated that compound 9 acts synergistically with metronidazole against a T. vaginalis metronidazole-resistant isolate. This report reveals the high potential of the triterpenoid derivative 9 as trichomonicidal agent.</description><identifier>ISSN: 0932-0113</identifier><identifier>EISSN: 1432-1955</identifier><identifier>DOI: 10.1007/s00436-018-5839-1</identifier><identifier>PMID: 29572567</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Animals ; Antitrichomonal Agents - pharmacology ; Biomedical and Life Sciences ; Biomedicine ; Cell Death - drug effects ; Cell Line, Tumor ; Cell lineage ; Chlorocebus aethiops ; Clinical isolates ; Condoms ; Cytotoxicity ; Drug Resistance ; Drug Synergism ; Drug Therapy, Combination ; Epithelium ; Female ; Health aspects ; HeLa Cells ; Hemolysis - drug effects ; Humans ; Immunology ; Medical Microbiology ; Metronidazole ; Metronidazole - pharmacology ; Microbial Sensitivity Tests ; Microbiology ; Minimum inhibitory concentration ; Nitroimidazole ; Original Paper ; Parasitic diseases ; Prevention ; Sexually transmitted diseases ; STD ; Terpenoids ; Trichomonas ; Trichomonas Infections - drug therapy ; Trichomonas Infections - parasitology ; Trichomonas vaginalis ; Trichomonas vaginalis - drug effects ; Trichomonas Vaginitis - drug therapy ; Trichomonas Vaginitis - parasitology ; Trichomoniasis ; Triterpenes - chemistry ; Triterpenes - pharmacology ; Ursolic Acid ; Vero Cells</subject><ispartof>Parasitology research (1987), 2018-05, Vol.117 (5), p.1573-1580</ispartof><rights>Springer-Verlag GmbH Germany, part of Springer Nature 2018</rights><rights>COPYRIGHT 2018 Springer</rights><rights>Copyright Springer Science &amp; Business Media 2018</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c439t-d6fb169625eece368d69bc17b70b69fc2bfe60952e9fb52da5132b2ee1be59ed3</citedby><cites>FETCH-LOGICAL-c439t-d6fb169625eece368d69bc17b70b69fc2bfe60952e9fb52da5132b2ee1be59ed3</cites><orcidid>0000-0002-8334-5105</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29572567$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bitencourt, Fernanda Gobbi</creatorcontrib><creatorcontrib>de Brum Vieira, Patrícia</creatorcontrib><creatorcontrib>Meirelles, Lucia Collares</creatorcontrib><creatorcontrib>Rigo, Graziela Vargas</creatorcontrib><creatorcontrib>da Silva, Elenilson Figueiredo</creatorcontrib><creatorcontrib>Gnoatto, Simone Cristina Baggio</creatorcontrib><creatorcontrib>Tasca, Tiana</creatorcontrib><title>Anti-Trichomonas vaginalis activity of ursolic acid derivative: a promising alternative</title><title>Parasitology research (1987)</title><addtitle>Parasitol Res</addtitle><addtitle>Parasitol Res</addtitle><description>Trichomonas vaginalis is an extracellular parasite that binds to the epithelium of the human urogenital tract and causes the sexually transmitted infection, trichomoniasis. In view of increased resistance to drugs belonging to the 5-nitroimidazole class, new treatment alternatives are urgently needed. In this study, eight semisynthetized triterpene derivatives were evaluated for in vitro anti- T. vaginalis activity. Ursolic acid and its derivative, 3-oxime-urs-12-en-28-oic-ursolic acid ( 9 ), presented the best anti- T. vaginalis activity when compared to other derivatives, with minimum inhibitory concentration (MIC) at 25 μM. Moreover, 9 was active against several T. vaginalis fresh clinical isolates. Hemolysis assay demonstrated that 9 presented a low hemolytic effect. Importantly, 25 μM 9 was not cytotoxic against the Vero cell lineage. Finally, we demonstrated that compound 9 acts synergistically with metronidazole against a T. vaginalis metronidazole-resistant isolate. This report reveals the high potential of the triterpenoid derivative 9 as trichomonicidal agent.</description><subject>Animals</subject><subject>Antitrichomonal Agents - pharmacology</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cell Death - drug effects</subject><subject>Cell Line, Tumor</subject><subject>Cell lineage</subject><subject>Chlorocebus aethiops</subject><subject>Clinical isolates</subject><subject>Condoms</subject><subject>Cytotoxicity</subject><subject>Drug Resistance</subject><subject>Drug Synergism</subject><subject>Drug Therapy, Combination</subject><subject>Epithelium</subject><subject>Female</subject><subject>Health aspects</subject><subject>HeLa Cells</subject><subject>Hemolysis - drug effects</subject><subject>Humans</subject><subject>Immunology</subject><subject>Medical Microbiology</subject><subject>Metronidazole</subject><subject>Metronidazole - pharmacology</subject><subject>Microbial Sensitivity Tests</subject><subject>Microbiology</subject><subject>Minimum inhibitory concentration</subject><subject>Nitroimidazole</subject><subject>Original Paper</subject><subject>Parasitic diseases</subject><subject>Prevention</subject><subject>Sexually transmitted diseases</subject><subject>STD</subject><subject>Terpenoids</subject><subject>Trichomonas</subject><subject>Trichomonas Infections - drug therapy</subject><subject>Trichomonas Infections - parasitology</subject><subject>Trichomonas vaginalis</subject><subject>Trichomonas vaginalis - drug effects</subject><subject>Trichomonas Vaginitis - drug therapy</subject><subject>Trichomonas Vaginitis - parasitology</subject><subject>Trichomoniasis</subject><subject>Triterpenes - chemistry</subject><subject>Triterpenes - pharmacology</subject><subject>Ursolic Acid</subject><subject>Vero Cells</subject><issn>0932-0113</issn><issn>1432-1955</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp1kV9LHDEUxYNU3K36AfpSBvo8NjeZZDZ9W8RWQfBF8TEkmZttlpmJTWYX_PaNjn8oWPKQcM_vXE44hHwBegaUtt8zpQ2XNYVVLVZc1XBAltBwVoMS4hNZUlXeFIAvyOect5RCK5vmiCyYEi0Tsl2S-_U4hfo2Bfc7DnE0udqbTRhNH3Jl3BT2YXqsoq92Kcc-uDILXdVhCntTRPxRmeohxSHkMG4q00-YxmfhhBx602c8fbmPyd3Pi9vzy_r65tfV-fq6dg1XU91Jb0EqyQSiQy5XnVTWQWtbaqXyjlmPkirBUHkrWGcEcGYZIlgUCjt-TL7Ne0uKPzvMk97GXcnQZ80op0w0ist3amN61GH0cUrGldROrwWXIICqVaHOPqDK6XAILo7oQ5n_Y4DZ4FLMOaHXDykMJj1qoPqpIT03pEtD-qkhDcXz9SXwzg7YvTleKykAm4FcpHGD6f1H_9_6F6Lfm2E</recordid><startdate>20180501</startdate><enddate>20180501</enddate><creator>Bitencourt, Fernanda Gobbi</creator><creator>de Brum Vieira, Patrícia</creator><creator>Meirelles, Lucia Collares</creator><creator>Rigo, Graziela Vargas</creator><creator>da Silva, Elenilson Figueiredo</creator><creator>Gnoatto, Simone Cristina Baggio</creator><creator>Tasca, Tiana</creator><general>Springer Berlin Heidelberg</general><general>Springer</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><orcidid>https://orcid.org/0000-0002-8334-5105</orcidid></search><sort><creationdate>20180501</creationdate><title>Anti-Trichomonas vaginalis activity of ursolic acid derivative: a promising alternative</title><author>Bitencourt, Fernanda Gobbi ; de Brum Vieira, Patrícia ; Meirelles, Lucia Collares ; Rigo, Graziela Vargas ; da Silva, Elenilson Figueiredo ; Gnoatto, Simone Cristina Baggio ; Tasca, Tiana</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c439t-d6fb169625eece368d69bc17b70b69fc2bfe60952e9fb52da5132b2ee1be59ed3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Animals</topic><topic>Antitrichomonal Agents - pharmacology</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cell Death - drug effects</topic><topic>Cell Line, Tumor</topic><topic>Cell lineage</topic><topic>Chlorocebus aethiops</topic><topic>Clinical isolates</topic><topic>Condoms</topic><topic>Cytotoxicity</topic><topic>Drug Resistance</topic><topic>Drug Synergism</topic><topic>Drug Therapy, Combination</topic><topic>Epithelium</topic><topic>Female</topic><topic>Health aspects</topic><topic>HeLa Cells</topic><topic>Hemolysis - drug effects</topic><topic>Humans</topic><topic>Immunology</topic><topic>Medical Microbiology</topic><topic>Metronidazole</topic><topic>Metronidazole - pharmacology</topic><topic>Microbial Sensitivity Tests</topic><topic>Microbiology</topic><topic>Minimum inhibitory concentration</topic><topic>Nitroimidazole</topic><topic>Original Paper</topic><topic>Parasitic diseases</topic><topic>Prevention</topic><topic>Sexually transmitted diseases</topic><topic>STD</topic><topic>Terpenoids</topic><topic>Trichomonas</topic><topic>Trichomonas Infections - drug therapy</topic><topic>Trichomonas Infections - parasitology</topic><topic>Trichomonas vaginalis</topic><topic>Trichomonas vaginalis - drug effects</topic><topic>Trichomonas Vaginitis - drug therapy</topic><topic>Trichomonas Vaginitis - parasitology</topic><topic>Trichomoniasis</topic><topic>Triterpenes - chemistry</topic><topic>Triterpenes - pharmacology</topic><topic>Ursolic Acid</topic><topic>Vero Cells</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bitencourt, Fernanda Gobbi</creatorcontrib><creatorcontrib>de Brum Vieira, Patrícia</creatorcontrib><creatorcontrib>Meirelles, Lucia Collares</creatorcontrib><creatorcontrib>Rigo, Graziela Vargas</creatorcontrib><creatorcontrib>da Silva, Elenilson Figueiredo</creatorcontrib><creatorcontrib>Gnoatto, Simone Cristina Baggio</creatorcontrib><creatorcontrib>Tasca, Tiana</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Parasitology research (1987)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bitencourt, Fernanda Gobbi</au><au>de Brum Vieira, Patrícia</au><au>Meirelles, Lucia Collares</au><au>Rigo, Graziela Vargas</au><au>da Silva, Elenilson Figueiredo</au><au>Gnoatto, Simone Cristina Baggio</au><au>Tasca, Tiana</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Anti-Trichomonas vaginalis activity of ursolic acid derivative: a promising alternative</atitle><jtitle>Parasitology research (1987)</jtitle><stitle>Parasitol Res</stitle><addtitle>Parasitol Res</addtitle><date>2018-05-01</date><risdate>2018</risdate><volume>117</volume><issue>5</issue><spage>1573</spage><epage>1580</epage><pages>1573-1580</pages><issn>0932-0113</issn><eissn>1432-1955</eissn><abstract>Trichomonas vaginalis is an extracellular parasite that binds to the epithelium of the human urogenital tract and causes the sexually transmitted infection, trichomoniasis. In view of increased resistance to drugs belonging to the 5-nitroimidazole class, new treatment alternatives are urgently needed. In this study, eight semisynthetized triterpene derivatives were evaluated for in vitro anti- T. vaginalis activity. Ursolic acid and its derivative, 3-oxime-urs-12-en-28-oic-ursolic acid ( 9 ), presented the best anti- T. vaginalis activity when compared to other derivatives, with minimum inhibitory concentration (MIC) at 25 μM. Moreover, 9 was active against several T. vaginalis fresh clinical isolates. Hemolysis assay demonstrated that 9 presented a low hemolytic effect. Importantly, 25 μM 9 was not cytotoxic against the Vero cell lineage. Finally, we demonstrated that compound 9 acts synergistically with metronidazole against a T. vaginalis metronidazole-resistant isolate. This report reveals the high potential of the triterpenoid derivative 9 as trichomonicidal agent.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>29572567</pmid><doi>10.1007/s00436-018-5839-1</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-8334-5105</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0932-0113
ispartof Parasitology research (1987), 2018-05, Vol.117 (5), p.1573-1580
issn 0932-0113
1432-1955
language eng
recordid cdi_proquest_journals_2030254936
source Springer Link
subjects Animals
Antitrichomonal Agents - pharmacology
Biomedical and Life Sciences
Biomedicine
Cell Death - drug effects
Cell Line, Tumor
Cell lineage
Chlorocebus aethiops
Clinical isolates
Condoms
Cytotoxicity
Drug Resistance
Drug Synergism
Drug Therapy, Combination
Epithelium
Female
Health aspects
HeLa Cells
Hemolysis - drug effects
Humans
Immunology
Medical Microbiology
Metronidazole
Metronidazole - pharmacology
Microbial Sensitivity Tests
Microbiology
Minimum inhibitory concentration
Nitroimidazole
Original Paper
Parasitic diseases
Prevention
Sexually transmitted diseases
STD
Terpenoids
Trichomonas
Trichomonas Infections - drug therapy
Trichomonas Infections - parasitology
Trichomonas vaginalis
Trichomonas vaginalis - drug effects
Trichomonas Vaginitis - drug therapy
Trichomonas Vaginitis - parasitology
Trichomoniasis
Triterpenes - chemistry
Triterpenes - pharmacology
Ursolic Acid
Vero Cells
title Anti-Trichomonas vaginalis activity of ursolic acid derivative: a promising alternative
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T22%3A34%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Anti-Trichomonas%20vaginalis%20activity%20of%20ursolic%20acid%20derivative:%20a%20promising%20alternative&rft.jtitle=Parasitology%20research%20(1987)&rft.au=Bitencourt,%20Fernanda%20Gobbi&rft.date=2018-05-01&rft.volume=117&rft.issue=5&rft.spage=1573&rft.epage=1580&rft.pages=1573-1580&rft.issn=0932-0113&rft.eissn=1432-1955&rft_id=info:doi/10.1007/s00436-018-5839-1&rft_dat=%3Cgale_proqu%3EA536151098%3C/gale_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c439t-d6fb169625eece368d69bc17b70b69fc2bfe60952e9fb52da5132b2ee1be59ed3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2030254936&rft_id=info:pmid/29572567&rft_galeid=A536151098&rfr_iscdi=true